CL2020002778A1 - Entrega objetivo de progestinas y estrógenos a través de dispositivos de anillo vaginal para el control de fertilidad y productos trh (hna. 2776-20) - Google Patents

Entrega objetivo de progestinas y estrógenos a través de dispositivos de anillo vaginal para el control de fertilidad y productos trh (hna. 2776-20)

Info

Publication number
CL2020002778A1
CL2020002778A1 CL2020002778A CL2020002778A CL2020002778A1 CL 2020002778 A1 CL2020002778 A1 CL 2020002778A1 CL 2020002778 A CL2020002778 A CL 2020002778A CL 2020002778 A CL2020002778 A CL 2020002778A CL 2020002778 A1 CL2020002778 A1 CL 2020002778A1
Authority
CL
Chile
Prior art keywords
progestins
estrogens
hna
target delivery
vaginal ring
Prior art date
Application number
CL2020002778A
Other languages
English (en)
Inventor
Klaus Nickisch
Karin Eggenreich
Walter Leger
Ze'ev Shaked
Simone Eder
Andreas Witschnigg
Original Assignee
Evestra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evestra Inc filed Critical Evestra Inc
Publication of CL2020002778A1 publication Critical patent/CL2020002778A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen diversos dispositivos de administración de fármacos intravaginales para la administración de estrógenos y progestinas. La tasa de liberación de estrógenos y progestinas se puede controlar variando el material de la matriz o mediante la aplicación de una capa fina. Los dispositivos de administración de fármacos intravaginales pueden estar compuestos por uno o más compartimentos individuales. Controlando varios parámetros físicos y químicos, se pueden lograr tasas de liberación de estrógenos o progestinas distintas de cero.
CL2020002778A 2018-04-27 2020-10-26 Entrega objetivo de progestinas y estrógenos a través de dispositivos de anillo vaginal para el control de fertilidad y productos trh (hna. 2776-20) CL2020002778A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862663584P 2018-04-27 2018-04-27

Publications (1)

Publication Number Publication Date
CL2020002778A1 true CL2020002778A1 (es) 2021-02-05

Family

ID=68291927

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2020002778A CL2020002778A1 (es) 2018-04-27 2020-10-26 Entrega objetivo de progestinas y estrógenos a través de dispositivos de anillo vaginal para el control de fertilidad y productos trh (hna. 2776-20)
CL2020002776A CL2020002776A1 (es) 2018-04-27 2020-10-26 Prodrogas estrógenas y métodos de administración de prodrogas estrógenas (hna. 2778-20)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2020002776A CL2020002776A1 (es) 2018-04-27 2020-10-26 Prodrogas estrógenas y métodos de administración de prodrogas estrógenas (hna. 2778-20)

Country Status (8)

Country Link
US (3) US20190328657A1 (es)
EP (2) EP3784247A1 (es)
AU (2) AU2019261454A1 (es)
BR (2) BR112020021994A2 (es)
CA (2) CA3098551A1 (es)
CL (2) CL2020002778A1 (es)
MX (2) MX2020011321A (es)
WO (2) WO2019210066A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019115343A1 (de) * 2019-06-06 2020-12-10 EVESTRA GmbH Vaginalring für die hormonelle Kontrazeption
WO2023200974A1 (en) * 2022-04-14 2023-10-19 Yale University Nanoparticles and nanoparticle-releasing vaginal rings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
US20110280922A1 (en) * 2008-11-07 2011-11-17 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
UY32492A (es) * 2009-03-17 2010-10-29 Organon Nv Dispositivo de suministro de droga zootécnica.
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device

Also Published As

Publication number Publication date
EP3784180A1 (en) 2021-03-03
BR112020021994A2 (pt) 2021-01-26
US20190328657A1 (en) 2019-10-31
AU2019257752A1 (en) 2020-12-03
CA3098551A1 (en) 2019-10-31
CA3098555A1 (en) 2019-10-31
MX2020011321A (es) 2021-02-09
MX2020011399A (es) 2020-11-24
CL2020002776A1 (es) 2021-02-05
WO2019210134A1 (en) 2019-10-31
US20190328656A1 (en) 2019-10-31
US20190328658A1 (en) 2019-10-31
WO2019210066A1 (en) 2019-10-31
BR112020021995A2 (pt) 2021-01-26
EP3784247A1 (en) 2021-03-03
AU2019261454A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
CL2020002778A1 (es) Entrega objetivo de progestinas y estrógenos a través de dispositivos de anillo vaginal para el control de fertilidad y productos trh (hna. 2776-20)
WO2017090019A3 (en) Devices, systems and methods for controlling environmental conditions of substances
CL2020002104A1 (es) Cambio de parte de ancho de banda y alineación de configuración física
AR121665A2 (es) Sistemas, métodos y aparatos de colocación de insumos agrícolas
MX2022015111A (es) Estructuras y sistemas de enfriamiento radiativo.
AU2018253515A1 (en) Substance delivery apparatus, substance delivery system and method of substance delivery
AU2014375677A1 (en) Drug dosing device and method for dosage metering and control
MX2022001477A (es) Configuracion de enlace lateral.
SG10201805220TA (en) Glass ceramic for ultraviolet lithography and method of manufacturing thereof
WO2015160741A3 (en) An apparatus for producing pouches
DK3455676T3 (da) Apparat til at præge diskrete substrater med et diskret fleksibelt stempel
WO2016064860A3 (en) Composition for forming a patterned metal film on a substrate
DE502008002148D1 (de) Arzneimittel umfassend wenigstens ein gestagen
BR112018069872A2 (pt) método para revestir um substrato com uma espuma, dispositivo de controle de emissões, e, usos de um dispositivo de controle de emissões e de uma camada de espuma sólida
CL2021002730A1 (es) Dispositivo y métodos de biorreactor.
HRP20191503T1 (hr) Sustav za isporuku lijeka koji sadrži ne-steroidni protuupalni lijek (nsaid) i progestogeni spoj i postupci za proizvodnju
AR089990A1 (es) Dispositivo con nucleo y recubrimiento para la liberacion de farmacos
MX2019001539A (es) Objetivo de pulverizacion catodica de calcogenuros y metodo para fabricarlo.
AR079028A1 (es) Metodo para evitar la cristalizacion de productos farmaceuticos en una pelicula polimerica
CO2020012951A2 (es) Métodos y aparatos para gestionar el tiempo de espera de rechazo
BR112021007268B8 (pt) Chuveiro de selador para depositar um selador sobre uma face de um substrato localizado abaixo do chuveiro de selador, defletor para formar uma parte de um chuveiro de selador, aparelho de revestimento de substrato, e, método para revestimento de um substrato com um selador pelo uso de um chuveiro de selador
CU20140094A7 (es) Sistema para la administración de fármacos
EP3497180A4 (en) LUMINESCENT NANO-SHEET PREPARATION METHOD, LUMINESCENT NANO-SHEET MATERIAL, LUMINESCENT NANO-SHEET FILM, BACKLIGHT AND LIQUID CRYSTAL DISPLAY APPARATUS
JP2015533104A5 (es)
NO20081488L (no) Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt